Cargando…

CIITA methylation and decreased levels of HLA-DR in tumour progression

Detalles Bibliográficos
Autores principales:	Iizuka, N, Oka, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364787/ https://www.ncbi.nlm.nih.gov/pubmed/15280925 http://dx.doi.org/10.1038/sj.bjc.6602045

Ejemplares similares

Reply: CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Morimoto, Y, et al.
Publicado: (2004)

CIITA promoter polymorphism impairs monocytes HLA-DR expression in patients with septic shock
por: Miatello, Jordi, et al.
Publicado: (2022)

The Relationship between HLA-B27, HLA-Cw06, HLA-DR7 and Psoriatic Arthritis in Vietnamese Patients: Disease Progression and Therapeutic Burden
por: Minh, Vinh Ngo, et al.
Publicado: (2019)

Letter Regarding “Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens”
por: El Ters, Mireille, et al.
Publicado: (2020)

HLA-DR expression in neonates after cardiac surgery under cardiopulmonary bypass: a pilot study
por: Chenouard, Alexis, et al.
Publicado: (2018)

Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITA
por: Codolo, Gaia, et al.
Publicado: (2020)

HLA-DR expression on monocytes is decreased in polytraumatized patients
por: Vester, Helen, et al.
Publicado: (2015)

CIITA and Its Dual Roles in MHC Gene Transcription
por: Devaiah, Ballachanda N., et al.
Publicado: (2013)

CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens
por: Forlani, Greta, et al.
Publicado: (2021)

Comparison of assays used for in vitro chemosensitivity testing of human tumours: Dr Wilson replies
por: Wilson, A.P.
Publicado: (1984)

Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens
por: Andeen, Nicole K., et al.
Publicado: (2020)

Response to Dr Fried & Dr Kievit, and Dr Malhi et al.
por: Schmaal, L, et al.
Publicado: (2016)

CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML
por: Satlsar, Esmaeil Shahabi, et al.
Publicado: (2020)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
por: Liu, Huan, et al.
Publicado: (2022)

HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia
por: Zi-Min, Sun, et al.
Publicado: (2010)

Protein arginine methyltransferase 1 (PRMT1) represses MHC II transcription in macrophages by methylating CIITA
por: Fan, Zhiwen, et al.
Publicado: (2017)

Comment: In Response to “CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML”
por: Gajendra, Smeeta
Publicado: (2020)

Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
por: Wu, Qi, et al.
Publicado: (2018)

Identification of CIITA Regulated Genetic Module Dedicated for Antigen Presentation
por: Krawczyk, Michal, et al.
Publicado: (2008)

A dual defensive role of CIITA against retroviral infections
por: Tosi, Giovanna, et al.
Publicado: (2006)

SIRT1 links CIITA deacetylation to MHC II activation
por: Wu, Xiaoyan, et al.
Publicado: (2011)

HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours.
por: Bártek, J., et al.
Publicado: (1987)

Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma
por: Kiuchi, Jun, et al.
Publicado: (2019)

Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239
Publicado: (1999)

Low levels of CIITA and high levels of SOCS1 predict COVID-19 disease severity in children and adults
por: Girona-Alarcon, Mònica, et al.
Publicado: (2021)

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes
por: Su, Chenhe, et al.
Publicado: (2021)

Interaction Analysis between HLA-DRB1 Shared Epitope Alleles and MHC Class II Transactivator CIITA Gene with Regard to Risk of Rheumatoid Arthritis
por: Ronninger, Marcus, et al.
Publicado: (2012)

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
por: Morimoto, Y, et al.
Publicado: (2004)

HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.
por: Matsushita, K., et al.
Publicado: (1996)

Decreased Monocyte HLA-DR Expression in Patients with Sepsis and Acute Kidney Injury
por: Wu, Huang-Pin, et al.
Publicado: (2022)

Author Response: Morphea, Gluten, and Autoimmunity: HLA Behind the Scenes?
por: Davis, Mitchell S., et al.
Publicado: (2021)

Decreased Serum Level of Interferon-γ in Patients with Pityriasis Rosea
por: Zeng, Ming, et al.
Publicado: (2014)

A call to establish HLA registry in Iraq
por: Al-Mendalawi, Mahmood D.
Publicado: (2023)

Is multiple sclerosis progression associated with the HLA-DR15 haplotype?
por: Stürner, Klarissa Hanja, et al.
Publicado: (2019)

Overexpression of CIITA in T Cells Aggravates Th2-Mediated Colitis in Mice
por: Kim, Tae Woon, et al.
Publicado: (2006)

IFN-γ and CIITA modulate IL-6 expression in skeletal muscle
por: Adhikari, Abhinav, et al.
Publicado: (2020)

Ultrasensitive tumour‐agnostic non‐invasive detection of colorectal cancer recurrence using ctDNA methylation
por: Xiao, Yu, et al.
Publicado: (2022)

A Case of Daratumumab-Induced Significant Decrease in Donor-Specific HLA Antibodies and Remission Induction Before Haploidentical Stem Cell Transplantation in a Refractory B-ALL Patient
por: Li, Xin, et al.
Publicado: (2022)

Dr Epenetos replies
por: Epenetos, A.A.
Publicado: (1986)

Dr. Andrade replies
por: Andrade, Chittaranjan
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_oolob2bpajh52o497po17vmps5